NCT06075316 Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
| NCT ID | NCT06075316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Condition | Thoracic |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-11-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-11-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-site, non-randomized study on the outcomes of remote real-time "ePRO monitoring" in thoracic surgery patients. ePRO monitoring is a health information technology intervention comprised of delivering longitudinal electronic patient-reported outcome (ePRO) surveys (e.g., on symptoms, and physical functioning) coupled with automated provider alerts for concerning survey responses.
Eligibility Criteria
Inclusion Criteria: Patients participating in ePRO monitoring must meet the following inclusion criteria to participate in this study: 1. 18 years or older 2. English or Spanish speaking 3. Able to complete a web-based, telephonic (IVR), or CRA (or other IRB-approved research team member)-administrated symptom survey 4. Planned to undergo major thoracic surgery (involving chest wall incisions and overnight admission) 5. Discharged from the thoracic surgery service 6. Discharged to home Exclusion Criteria: All patients meeting any of the following exclusion criteria at enrollment will be excluded from study participation: 1. Not completing planned surgery within 3 months of obtaining informed consent 2. Inability to understand English or Spanish 3. Having undergone only minor thoracic surgery (e.g. bronchoscopy, cervical mediastinoscopy) 4. Dementia, altered mental status, or any psychiatric condition determined by the thoracic surgery provider team that would prohibit the understanding or rendering of informed consent. 5. Current incarceration 6. Pregnancy
Contact & Investigator
Gita Mody, MD, MPH
PRINCIPAL INVESTIGATOR
University of North Carolina, Chapel Hill
Frequently Asked Questions
Who can join the NCT06075316 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Thoracic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06075316 currently recruiting?
Yes, NCT06075316 is actively recruiting participants. Contact the research team at Amanda_gentry@med.unc.edu for enrollment information.
Where is the NCT06075316 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT06075316 clinical trial?
NCT06075316 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Gita Mody, MD, MPH at University of North Carolina, Chapel Hill. The trial plans to enroll 200 participants.